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Background: Numerous	 frameworks	 for	 supporting,	 evaluating	and	 reporting	patient	
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The	 second,	 which	 some	 have	 described	 as	 consequentialist	
or	 efficiency‐oriented,3	 is	 that	 patient	 and	 public	 involvement,	 by	
bringing	 a	 real‐world	 and	 lived‐experience	 perspective,	 improves	
the	efficiency	and	value	of	 research	via	a	number	of	mechanisms:	
increasing	 its	 relevance	to	patients;	 improving	recruitment	and	re‐
tention	rates	of	research	participants;	extending	the	range	of	peo‐
ple	represented	in	research	studies;	and	improving	dissemination	of	
findings	 beyond	 academic	 audiences6,7,10,11—though	 the	 evidence	
base	for	all	these	claims	has	been	questioned.10,12
The	 third	 argument	 is	 political	 and	 practical:	 that	 forming	 alli‐
ances	with	patients	and	the	public	is	a	defining	feature	of	contem‐




Notwithstanding	 the	 different	 (and	 to	 some	 extent	 incom‐
mensurable)	 perspectives	 represented	 by	 the	 above	 literature,	
it	 is	 clear	 that	 improving	 patient	 and	 public	 involvement	 in	 re‐
search	 is	a	high	priority	for	research	policymakers,14‐16	research	
funders,17‐20	 researchers,21‐23	 some	 academic	 journals1	 and	 pa‐
tient	and	lay	organizations.24‐26	Many	of	these	groups	have	devel‐
oped,	or	are	in	the	process	of	developing,	structured	frameworks,	




UK's	 leading	medical	 and	 biotechnology	 research	 regions,	we	had	















a	 new	 framework	 from	 scratch	was	 almost	 certainly	 unnecessary,	
but	that	the	existing	 literature	could	benefit	from	a	taxonomy	and	
improved	accessibility.
Accordingly,	 we	 set	 out	 to	 achieve	 three	 objectives.	 First,	 to	
identify,	critically	examine,	summarize	and	synthesize	existing	tools,	
frameworks,	benchmarks,	guidelines	and	critical	appraisal	checklists	
for	patient	 and	 lay	 involvement	 in	 research.	 Second,	 to	determine	
which	of	the	frameworks	were	actually	used	and	why	(and	explain	
why	 others	 were	 not	 used).	 Third,	 to	 work	 with	 patient	 and	 lay	
groups	and	designers	to	adapt,	simplify	and	annotate	existing	frame‐
works	and	improve	their	aesthetic	appeal	and	usability.	As	the	study	
unfolded	 (and	 for	 reasons	 explained	 in	 the	 results	 section	 below),	
this	last	aim	evolved	to	incorporate	a	major	focus	on	optimizing	the	
process	of	running	workshops	aimed	at	generating,	adapting	and	op‐




Narrative	 systematic	 review,	 drawing	 on	 the	 principles	 of	 her‐
meneutic	 review,28	 along	 with	 lay	 consultation	 and	 co‐design.29 
Hermeneutic	 review	consists	of	 two	 interlinked	cycles	 (described	
in	more	detail	below):	 (a)	accessing	and	 interpreting	the	 literature	
and	(b)	developing	an	argument.	Searching	is	systematic	but	flexible	
and	 iterative.	As	sources	accumulate,	 it	becomes	necessary	to	 in‐
terpret,	clarify	and	understand	the	emerging	ideas	and	perspectives	











egy	 used	 by	 previous	 authors31):	 (a)	 consumer	 or	 community	 or	
patient	 or	 citizen	 or	 user	 or	 lay	 or	 public	 or	 stakeholder;	 (b)	 par‐
ticipate	or	engage	or	involve	or	consult	or	empower	or	collaborate	
or	 inform;	 (c)	 health	 or	 medical	 or	 biomedical	 or	 nursing;	 (d)	 re‐
search	 or	 evaluation;	 (e)	 tool	 or	 toolkit	 or	 framework	 or	 guideline	
or	checklist.	We	hand‐searched	eight	journals	(Health Expectations,	
BMC Research Involvement and Engagement,	 International Journal of 
Consumer Studies,	 International Journal of Technology Assessment in 
Health Care,	Health Research Policy and Systems,	BMC Health Services 
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Research,	International Journal of Healthcare Quality Assurance and 
BMJ Open)	from	January	2008	to	December	2018.
We	also	searched	selected	grey	literature	sources	(eg,	guidance	
produced	 by	 national	 and	 international	 patient	 organizations	 and	
advocacy	groups,	health	services	or	think	tanks),	collated	sources	al‐
ready	known	to	the	authors	and	put	out	requests	to	our	professional	
networks	 (including	 social	 media	 followers).	 When	 we	 identified	
papers	 that	met	 our	 inclusion	 criteria,	we	 checked	 the	 references	
of	those	papers	and	also	put	the	title	into	Google	Scholar	to	subse‐
quent	citations	of	it	(an	“ancestry	and	snowball”	approach32).	Where	




2.3 | Inclusion and exclusion criteria
We	included	any	published,	systematic	approach	designed	to	inform,	





ment	 (defined	 as	 explaining	 research	 to	 the	public)	 as	 opposed	 to	
involvement	(involving	patients	and	the	public	in	some	way	in	plan‐
ning,	undertaking	and	disseminating	research).	Largely	for	practical	
purposes,	grey	 literature	was	 limited	 to	publications	 from	national	
or	 international	 organizations	 (eg,	 James	 Lind	 Alliance,	 INVOLVE,	
Canadian	Institute	for	Health	Research).
2.4 | Data extraction and appraisal of quality
We	used	 an	 Excel	 spreadsheet	 to	 summarize	 key	 aspects	 of	 each	












Using	 data	 from	 these	 domains,	 we	 applied	 the	 Canadian	
Centre	for	Excellence	on	Partnerships	with	Patients	and	the	Public	





•	 comprehensiveness	 (graded	 as	 3	=	good,	 covering	 all	 intended	
dimensions;	 2	=	limited,	 covering	 only	 some	 key	 dimensions;	
1	=	very	limited);	and
•	 usability	 (graded	as	3	=	good,	extensive	evidence	of	use	beyond	
the	study	 in	which	 it	was	developed;	2	=	emerging	 [for	 recently	
published	frameworks	with	some	evidence	of	use];	1	=	limited	or	
unknown).
2.5 | Analysis and synthesis of primary literature




As	 an	 example	 of	 our	 approach,	 our	 hand	 search	 turned	 up	 a	
paper	by	Staniszewska	et	al33	on	the	GRIPP1	(Guidance	for	Reporting	
Involvement	of	Patients	and	Public)	framework	for	structuring	how	
researchers	 report	 lay	 involvement	 in	a	clinical	 trial.33	Through	ci‐
tation	tracking	of	 that	paper,	we	 identified	a	number	of	additional	
“report‐focused”	 frameworks,34‐36	 including	 GRIPP2.34	 Whilst	 we	
initially	 grouped	 all	 these	 as	 a	 subset	 of	 frameworks	 designed	 for	
planning	 and	 organizing	 patient	 involvement	 in	 research	 studies	
(“study‐focused”),	detailed	analysis	 revealed	that	these	were	sepa‐
rate	categories	with	limited	cross‐referencing	between	them.
We	 synthesized	 a	 preliminary	 set	 of	 resources	 based	 on	 the	
frameworks	 in	 our	 data	 set.	 To	 inform	 the	 practical	 workshops,	
rather	than	reproduce	all	the	frameworks	(since	many	covered	sim‐
ilar	ground),	we	worked	with	 lay	colleagues	 to	 select	 the	 “best‐in‐
class”	from	different	categories	in	our	data	set.	In	this	process,	we	









research	 partnerships	 (including	 researchers,	 patient	 involvement	
leads,	patients,	 carers	and	advocates).	We	adapted	 the	 interactive	
and	participatory	methodology	described	by	previous	authors.29,37 
Prior	to	the	first	workshop,	we	made	large‐scale	diagrams	of	the	dif‐





The	 workshop	 materials,	 suggested	 format,	 resources	 and	 fa‐
cilitator	notes	produced	 in	 the	 two	development	workshops	were	
refined	 through	 three	 further	 pilot	workshops	 in	 contrasting	 clin‐
ical	 and	 research	 settings:	 a	 long‐established	patient	 participation	
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group	for	a	specialist	research	group	in	blood	disorders;	a	recently	
established	lay	partner	group	for	a	community‐based	mental	health	
research	 programme;	 and	 an	 academic‐lay‐industry	 partnership	
seeking	to	establish	working	principles	and	evaluation	methods	for	
lay	 participation	 in	 industry‐led	 clinical	 trials.	 Full	 details	 of	 these	
workshops	will	be	presented	in	a	separate	paper.
3  | RESULTS
3.1 | Description of data set
The	 study	 flow	 chart	 is	 shown	 in	 Figure	 1.	Of	 over	 5000	 titles,	
150	papers	were	retrieved	in	full	text;	this	sample	was	extended	
to	 250	 using	 ancestry	 and	 snowball	 searches.	 After	 applying	
exclusion	 criteria,	 our	 final	 data	 set	 consisted	 of	 64	 papers	 de‐
scribing	 65	 frameworks	 from	10	 countries	 (one	 paper	 described	
two	frameworks35):	UK	 (34	papers5,12,27,33‐36,38‐64),	United	States	
(14	 papers10,65‐77),	 Canada	 (7	 papers20,78‐83),	 Netherlands	 (3	 pa‐
pers84‐86)	and	one	paper	each	from	Australia,31	Spain,87	Zambia,88 
a	WHO	 consortium	 led	 from	 Switzerland,89	 a	 Southern	 African	
consortium	 led	 from	 South	 Africa90	 and	 a	 European	 consortium	
led	from	Belgium.91
The	 included	 publications	 described	 toolkits,	 tools,	 frame‐
works,	 checklists,	 benchmarks	 or	 maps	 for	 informing,	 guiding,	
assessing	or	 reporting	on	patient	and/or	public	 involvement	 in	 re‐













realist	 review	 (asking	 “what	 works	 for	 whom	 in	 what	 cir‐
cumstances”),48,79,80	 a	 consensus‐building	 process	 such	 as	
Delphi34,38,52,58,69	 or	 economic	 modelling.71	 Other	 frameworks	
had	been	developed	in	a	more	pragmatic	way	by	working	groups	
(typically	 involving	 lay	 people,	 researchers	 and/or	 research	
funders)	 with	 extensive	 consultation	 but	 without	 an	 in‐depth	
review	 of	 the	 relevant	 academic	 literature.20,27,36,59,69,78,91	 Some	
groups	 used	 a	 combination	 of	 literature	 review,	 qualitative	 re‐
search	 and	 workshops.31,34,53,58,65,72,73,75,77,80‐82,85,88,89	Some	












1.	 Power‐focused:	 designed	 to	 surface,	 explore	 and	 overcome	
researcher‐lay	 power	 imbalances;
2.	 Priority‐setting:	 designed	 to	 involve	 patients	 and	 lay	 people	 in	
setting	research	priorities;
F I G U R E  1  Study	flow	chart





































to	 those	 in	 other	 categories	 in	 our	 taxonomy,	 they	 asked	 more	
TA B L E  1  Taxonomy	of	frameworks	for	supporting	and	evaluating	patient	and	public	involvement	in	research
Category with selected “best in 


















































































empowerment	 is?”	 and	 “whose	 interests	 are	 served	by	 so‐called	
empowerment?”
The	earliest	power‐focused	 framework	 in	our	data	 set	was	 led	
by	 Oliver's	 group	 at	 the	 Institute	 of	 Education.	 It	 was	 published	






al5	 subsequently	updated	and	extended	 this	 framework	 further	 to	





Morrow	 et	 al42	 developed	 a	 Quality	 Involvement	 Framework	
based	on	Foucauldian	notions	of	power	and	depicting	both	a	user	
perspective—what	 was	 the	 individual	 able to do	 (eg,	 access	 re‐
sources);	what	 could	 they	potentially do	 (eg,	 apply	 for	 a	 role);	 and	
what	did	they	feel	(eg,	valued,	empowered,	conscious	of	power	dy‐
namics)—and	 a	 corresponding	 research	 context	 perspective—com‐
prising	research	relationships,	ways	of	doing	research	and	research	
structures	(see	Appendix	S1	for	full	questionnaire).
Prainsack,	 whose	 theoretical	 starting‐point	 was	 the	 “open‐
ing‐up”	 of	 science	 proposed	 by	 sociologists	 of	 science	 such	 as	
Nowotny,95	worked	with	 various	 genetics	 alliances	 to	 produce	 a	
set	of	six	principles	for	genetic	research;	many	of	the	questions	are	
framed	explicitly	 in	terms	of	power	 (“who	sets	the	agenda?”;	 “by	
whom	is	it	decided	what	good	outcomes	are?”;	“who	has	access	to	
what	data?”).43
Power‐focused	 frameworks	 exploring	 the	 values	 and	 eth‐
ical	 principles	 of	 lay	 involvement	 in	 research	 (see	 examples	 in	
Appendix	S1)40,41,45	appear	to	have	informed	the	subsequent	de‐
velopment	 of	 more	 pragmatic,	 partnership‐focused	 frameworks	
(discussed	below).
Some	 publications	 addressed	 researcher‐community	 power	
differentials	 through	 the	 lens	 of	 community‐based	 participa‐
tory	 research,65‐67,76	 including	 a	 comprehensive	 framework	 syn‐








Two	 recent	 frameworks	were	 published	 from	 the	US	 Patient‐
Centered	 Outcomes	 Research	 Institute	 (PCORI),	 an	 arms‐length	
government	 organization	 (and	 leading	 funder	 of	 patient	 involve‐
ment	 research)	whose	main	 goal	 is	 ensuring	 that	 comparative	 ef‐
fectiveness	 studies	 address	 outcomes	 relevant	 to	 patients.	 One	
paper	described	a	framework	for	extending	such	research	with	the	
principles	of	community‐based	participatory	research,	with	a	view	





framework	 for	 guiding	 the	 involvement	 of	 poor	 and	 underserved	
populations	in	research	using	routinely	collected	data	from	patient	
health	records.77
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3.3 | Priority‐setting frameworks
Eight	 frameworks,	 from	 Canada,78	 Netherlands,86	 Switzerland,89 
UK,36,46 Zambia88	and	United	States,68,69	summarized	guidance	for	
a	structured	process	to	help	ensure	that	patients	and	lay	people	are	
involved	 (along	 with	 clinicians	 and	 researchers)	 in	 deciding	 which	
topics	to	prioritize	for	future	research.
In	2003,	Lomas	et	al78	published	the	output	of	a	Canadian‐UK	






the	 identified	 priority	 issues	 against	 other	 sources	 of	 similar	 in‐






preliminary	 steps	 (understand	 the	 national	 and	 local	 context,	 and	











The	 UK‐based	 James	 Lind	 Alliance	 developed	 a	 framework	
for	 topic‐focused	 priority‐setting	 partnerships	 oriented	 mainly	
to	 the	design	of	new	clinical	 trials	 in	2008	and	updated	 in	2013	
(Figure	 3).36	 They	 emphasized	 five	 principles:	 transparency	 of	
process;	 balanced	 inclusion	 of	 patient,	 carer	 and	 clinician	 inter‐




A	 similar	 framework,	 oriented	 to	 priority‐setting	 in	 comparative	
effectiveness	 research,	 was	 produced	 by	 PCORI	 in	 the	 United	
States.68
Pollock	et	al36	adapted	the	James	Lind	Alliance	methodology	
to	 increase	participation	by	a	potentially	 excluded	group	 (stroke	
patients	with	aphasia).	Modifications	included	visits	to	individuals'	










Whilst	 the	 James	 Lind	 Alliance	 drew	 on	 the	 principles	 of	
power‐sharing	developed	by	Oliver	et	al,44	critical	social	scientists	






Of	 19	 frameworks	 in	 this	 category	 (from	 UK,12,35,47‐52	 United	
States,70‐75	 Canada,79‐81	 Spain87	 and	 Southern	 Africa90),	 14	 were	
based	 on	 a	 more	 or	 less	 linear	 model	 of	 a	 clinical	 trial	 and	 pro‐
posed	how	patient	 and	 lay	 involvement	 could	 be	woven	 into	 it	 at	
every	 stage	 from	 writing	 the	 proposal	 to	 disseminating	 the	 find‐
ings.12,35,47,48,51,70,72,73,75,79‐81,87,90	 One	 framework	 focused	 on	 the	
phase	before	formal	ethical	approval	was	gained50	and	one	on	the	
involvement	of	patients	in	setting	clinical	outcomes.74	One	consid‐
ered	the	economic	costs	and	benefits	of	 lay	 involvement	 in	differ‐
ent	phases	of	a	clinical	trial71;	and	one	addressed	how	to	maintain	










the	authors,	patient	and	 lay	 input	 throughout	a	clinical	 trial	would	
make	 the	 trial	 more	 relevant,	 more	 appealing	 to	 potential	 partic‐
ipants,	 more	 likely	 to	 reach	 its	 target	 recruitment,	 more	 likely	 to	
retain	participants	and	more	likely	to	generate	and	disseminate	high‐
quality	research	knowledge.
Whilst	 study‐focused	 frameworks	 differed	 in	 detail,	 common	
features	 included	 the	need	 to:	 (a)	assess	and	understand	 the	 local	
context	 and	nature	of	 the	proposed	 study;	 (b)	 plan	 ahead	 and	 re‐
source	each	step	adequately;	 (c)	go	beyond	tokenism	(eg,	ensuring	
that	patient	 involvement	 is	more	 than	 “ticking	a	box”);	 (d)	 address	
inclusivity	 (eg,	 by	 developing	 research	 capacity	 in	 satellite	 clinics	







One	 paper	 proposed	 a	 set	 of	 “ethical”	 questions	 to	 ask	 about	
user	 involvement	 in	 relation	 to	a	 clinical	 trial35:	Are	users	 fully	 in‐
formed	about	the	proposed	study?;	Are	they	able	to	opt	out?;	Are	










ership	 by	 the	 principal	 investigator,	 a	 culture	 of	 involvement)	 and	











improves	 the	 participant	 experience,	 leading	 to	 fewer	 withdrawals	
from	the	study	(again,	with	major	predicted	cost	savings).
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F I G U R E  4  Example	of	study‐focused	framework	for	patient	and	lay	involvement	in	research,	reproduced	with	permission	from	the	NIHR	
Research	Design	Service51
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Two	 recently	 published	 study‐focused	 frameworks	 included	
an	 additional	 dimension	 of	measuring	 the	 impact	 of	 such	 involve‐
ment.68,72	Dillon	et	al,73	for	example,	used	a	literature	review	along	
with	user	workshops	to	develop	the	Critical	Outcomes	of	Research	
Engagement	 (CORE)	 framework	shown	 in	Figure	5,	 through	which	










one	covered	systematic	 reviews.53	All	addressed	 (at	 least	 in	broad	










Seventeen	 frameworks	 (from	 United	 States,10	 Canada,20,82 
Australia,31	 UK,27,54‐61	 the	 Netherlands84,85	 and	 Belgium91)	 were	
classified	as	predominantly	partnership‐focused,	 in	 that	 they	were	
explicitly	designed	to	optimize	collaborative	partnerships	between	
researchers	 and	 lay	 people	 or	 lay	 organizations	 and	measure	 key	





The	 James	 Lind	 Alliance	 (described	 above	 in	 the	 “Priority‐set‐
ting”	category	above)	was	one	of	the	first	groups	to	propose	some	
F I G U R E  5  Example	of	study‐focused	framework	for	measuring	the	impact	of	patient	and	lay	involvement	in	research,	reproduced	under	
Creative	Commons	licence	from	Dillon	et	al73
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core	 principles	 underpinning	 research	 partnerships	 with	 patients	
and	 the	public:	 transparency,	 balance,	 exclusion	of	 conflicts	of	 in‐
terest,	and	audit.46
Boote	 et	 al38	 in	 2006	 used	 an	 extensive	 Delphi	 process	 to	
generate	eight	principles	(including	agreed	roles,	reimbursement,	
respect	 and	 training),	 each	with	 an	 audit	 indicator,	 for	 support‐
ing	 researcher‐lay	partnerships	more	generally	 (see	Appendix	S1	
for	details).	These	early	 initiatives	are	typical	of	approaches	that	





A	 number	 of	 academic‐lay	 partnerships	 have	 produced	 simi‐
lar	 frameworks,	 typically	 as	 a	 result	 of	 hybrid	 funding	 from	aca‐
demic,	 service	 and	patient	organizations.31,41,55,59‐61,77,79,82,84,85,91 
Common	 themes	 in	 this	 category	 included	 governance	 mecha‐
nisms	including	formal	power‐sharing	arrangements	(eg,	co‐chair‐
ing);	good	leadership	and	project	management;	clear	and	effective	
communication	 (including	 commitment	 to	 listening	 and	 respond‐
ing);	 mechanisms	 to	 ensure	 inclusivity	 (eg,	 outreach,	 reimburse‐
ment);	 training	 and	 capacity‐building	 (of	 both	 researchers	 and	





based	 consortium's	 “UK	 PPI	 Standards	 for	 public	 involvement	 in	
research”	 (inclusive	 opportunities,	 working	 together,	 support	 and	
learning,	 communications,	 impact	 and	 governance),	 published	 in	
March	2018.27	These	six	standards	were	produced	by	a	partnership	









3.7 | Evidence of framework use
The	only	dimension	of	the	CEPPP	tool	on	which	a	high	proportion	
of	frameworks	scored	poorly	was	usability	(which	we	interpreted	to	
include	 actual	 evidence	 of	 use).	 Power‐focused	 frameworks	 were	
rarely	used	directly,	but	they	informed	and	underpinned	subsequent	
work	 on	 more	 applied	 categories	 of	 framework.46,51,58	 Some	 but	
not	 all	 priority‐setting,46,78,85	 study‐focused79‐81	 and	 partnership‐









same	 field,	 dissemination	occurred	via	 conferences	and	 topic‐spe‐
cific	clinical	research	networks	(personal	communications	from	lead	
authors).




munication	 from	 lead	author).	A	search	of	 the	published	academic	
literature	using	Google	Scholar	identified	only	rare	instances	of	one	
research	group	describing	the	application	of	a	framework	developed	
by	 another	 group,92,99	 though	we	 acknowledge	 that	we	may	 have	
missed	other	examples.	Only	one	framework	in	our	sample	reported	
formal	usability	 testing.82	At	 the	time	of	writing,	 the	UK	PPI	stan‐
dards	are	being	piloted	for	usability	in	10	testbeds	and	49	additional	






Our	 data	 set	 also	 revealed	 a	 number	 of	 examples	 of	 efforts	
to	 operationalize	 a	 theoretically	 derived	 framework	using	 some	
kind	of	practical	workshop.	For	example,	the	Public	Involvement	















TA B L E  2  Example	of	report‐focused	
framework:	GRIPP2	short	form





play”	workshop	 to	 surface	 and	 explore	 researchers'	 willingness	
to	 share	power	with	 lay	partners,	 and	Dillon	et	 al's73	 facilitated	
workshop	 to	 finalize	 and	operationalize	 their	Critical	Outcomes	
of	 Research	 Engagement	 (CORE)	metrics	 for	measuring	 the	 im‐





Following	our	 two	preliminary	development	workshops,	 the	 three	
co‐design	workshops	 involved	a	 total	of	30	participants	 (including	
people	who	identified	primarily	as	patients,	carers	and	service	users,	
those	 who	 worked	 in	 facilitation	 or	 advocacy	 roles,	 researchers,	







quality	 of	 facilitation).	 None	 of	 the	workshops,	 even	 those	work‐
ing	with	well‐established	 patient	 involvement	 groups,	 produced	 a	
definitive	framework,	which	suggests	that	a	frameworking	process	




4.1 | Summary of principal findings






Second,	we	 have	 developed	 a	 new	 taxonomy	 of	 these	 frame‐
works—power‐focused,	 priority‐setting,	 study‐focused,	 report‐fo‐
cused	 and	partnership‐focused—based	on	 their	 primary	 focus	 and	
intended	purpose.
Third,	 we	 have	 ascertained	 that	 most	 published	 frameworks	
have	been	little	used	beyond	the	groups	that	developed	them	(with	





Whilst	 the	 frameworks	 in	 our	 data	 set	were	 developed	 in	 dif‐
ferent	ways	and	for	diverse	reasons	and	use	cases,	 the	similarities	
among	them	were	as	striking	as	their	differences.	Almost	all	authors	
warned	 about	 the	 dangers	 of	 tokenism	 and	 tick‐box	 approaches;	
encouraged	efforts	to	extend	the	diversity	and	representativeness	
of	 patient	 and	 lay	 input;	 emphasized	 that	 democratic	 values	 and	
TA B L E  3  Example	of	partnership‐focused	framework:	the	INVOLVE	values	and	principles	framework














































mon	 set	 of	 evidence‐based	 resources	 can,	 when	 used	 to	 support	
facilitated	design,	produce	different	kinds	of	framework	to	suit	the	
needs	of	different	groups.
4.2 | Comparison with other studies
Four	 previous	 “framework	 of	 frameworks”	 publications	 offered	 a	
taxonomy	 of	 published	 approaches	 to	 patient	 and	 lay	 involvement	
in	health	research,	though	each	took	a	narrower	focus	than	our	own	






ment	 in	 research	 (not	 limited	 to	 health).63	 Hughes	 and	 Duffy	 used	
concept	analysis	 to	consider	how	power‐sharing	had	been	theorized	
in	previous	public	 involvement	 frameworks.62	Boivin	et	al83	 summa‐
rized	and	critiqued	evaluation	tools	for	patient	and	lay	involvement	in	
research.
The	 emerging	 literature	 on	 the	 use	 of	 practical	 workshops	 in	
knowledge	creation	helps	explain	why	our	 focus	on	building	one's	
own	framework	appeared	to	be	more	successful	than	inviting	groups	
to	 use	 off‐the‐shelf	 frameworks.	 This	 literature	 includes	 reviews	
of	 approaches	 to	 co‐creation	 of	 knowledge102	 and	 the	 sociology	
of	design,103	and	(more	specifically	relevant	to	our	empirical	work)	




jargon,	 gives	 voice,	 sparks	 ideas,	 inspires	 motivation,	 helps	 ar‐




knowledge,	 and	 retains	a	pragmatic	 focus	on	using	knowledge);	
and
•	 influence	 on	 the	 process of implementation	 (the	 intervention	
generated	 through	 creative	 play	 is	 “owned”	 by	 end‐users;	 the	





The	 shift	 in	our	 focus	 from	 identifying	published	 frameworks	 to	





knowledge	 as	 socially	 constructed	 and	 perspectival)	 to	 a	 hands‐on	
view	of	knowledge	(known	as	performative	and	defined	as	something	
that	 is	brought	 into	being	 in	and	 through	human	action).102	 In	other	
words,	actively	building	a	framework	may	be	more	effective	and	en‐
during	 than	attempting	 to	 apply	 someone	else's	 framework.	Van	de	
Ven	 and	 Johnson104	 explain	 how	 the	 principles	 and	 philosophy	 of	
pragmatism	 (attending	primarily	 to	 the	practical	 and	context‐depen‐
dent	use	to	which	the	outputs	of	practical	work	will	be	put)	can	aid	a	





an	 academic	 ideal	 and	a	 local,	 pragmatic	 solution.	Deborah	Ghate	
recently	described	an	attempt	to	co‐produce	a	parenting	programme	
that	was	both	 “evidence‐based”	 (ie,	 drawing	on	 the	 research	 liter‐













tion	 and	 theoretical	 analysis,	we	 have	 produced	 a	 new	 taxonomy	
into	which	future	studies	can	be	classified—and	which	has	the	po‐
tential	to	be	extended	if	other	groups	develop	new	approaches	to	
exploring	 the	 field.	This	 is	also	 the	 first	 systematic	 review	on	 this	
topic	to	have	gone	beyond	an	academic	synthesis:	we	produced,	and	
empirically	 tested,	a	set	of	 resources	 intended	for	use	 in	practical	
workshops,	allowing	different	 researcher‐lay	partnerships	 to	draw	
on	them	in	different	ways	through	evidence‐informed	serious	play.
One	 limitation	of	 this	 review	 is	 that	 few	primary	 studies	were	









tial	 range	 of	 diversity	 of	 such	 partnerships.	Whilst	we	 believe	we	
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have	demonstrated	proof	of	 concept	 for	our	 “co‐design	 your	own	
framework”	approach,	we	 invite	other	groups	 to	explore	 their	use	
of	our	workshop	resources	and	facilitator	guides	in	a	wider	range	of	
target	groups	and	settings.	We	have	made	these	resources	available	




porting	 and	 evaluating	 patient	 and	 public	 involvement	 in	 research	
already	 exist.	 They	 have	 different	 provenances,	 intended	purposes,	
strengths	and	limitations.	But	being	evidence‐based	and	theoretically	
informed	is	no	guarantee	that	a	framework	will	be	used.	A	single,	one‐




patient	 or	 lay	 involvement	 in	 their	 own	 research	 use	 a	 three‐step	
process.	 First,	 explore	 the	 published	 examples	 described	 in	 this	
paper	 and	 the	 Appendix	 S1.	 Depending	 on	 context	 and	 intended	
use	case,	a	framework	may	be	found	that	is	fit	for	purpose—perhaps	
with	some	adaptation.	In	the	absence	of	such	a	framework,	down‐
load	and	study	 the	 facilitator	guide	and	evidence‐based	 resources	
and	prompts,	which	are	based	on	the	findings	of	this	review.	Finally,	
work	with	patient	collaborators	and	(ideally)	professional	facilitators	




staff	 who	 attended	 the	 co‐design	 workshops,	 without	 whom	 this	
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